Patients with Combination of Cardiovascular Diseases and Type 2 Diabetes in RECVASA and REGION Registries: Multimorbidity, Outcomes and Potential Effect of Dapagliflozin in the Russian Clinical Practice

Patients with Combination of Cardiovascular Diseases and Type 2 Diabetes in RECVASA and REGION Registries: Multimorbidity, Outcomes and Potential Effect of Dapagliflozin in the Russian Clinical Practice

Aim. To evaluate the structure of multimorbidity, outcomes and the potential effect of dapagliflozin in patients with a combination of cardiovascular disease (CVD) and type 2 diabetes in Russian clinical practice.Material and methods. The data of 10 registries with the inclusion of 22957 people, inc...

Full description

Bibliographic Details
Main Authors: M. M. Loukianov, A. V. Kontsevaya, A. O. Myrzamatova, M. B. Khudyakov, E. Y. Okshina, E. V. Kudryashov
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2020-03-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
cardiovascular diseases
diabetes
outpatient and hospital registries
follow-up
outcomes
dapagliflozin
Online Access:https://www.rpcardio.com/jour/article/view/2124

Internet

https://www.rpcardio.com/jour/article/view/2124

Similar Items